Chronic Pain Panel

The Fagron Chronic Pain Panel is an innovative genetic test that offers hope for those living with persistent pain by revealing how your genetic profile influences pain perception and response to treatments. This non-invasive cheek swab test analyzes key single nucleotide polymorphisms (SNPs) related to pain sensitivity, inflammation, and medication metabolism, conducted in a certified laboratory. 

For those battling chronic pain conditions like neuropathy, migraines, or fibromyalgia, this panel provides a personalized path to relief by guiding healthcare providers to tailor treatments, such as specific medications, supplements, or therapies, that align with your unique genetic makeup. By understanding your body’s pain pathways, you can move beyond generic solutions, reducing side effects and improving treatment efficacy. This test empowers you and your provider to make informed decisions, offering a proactive approach to managing chronic pain and enhancing your quality of life.

Why Choose This Panel?
Choose the Chronic Pain Panel if you’re struggling with persistent pain and seeking targeted relief strategies. Unlike the Pharmacogenomic (PGx) Panel, which broadly optimizes medication response, or the Neurological Psych Panel, which focuses on mental health, this panel specifically addresses pain perception and inflammation, making it ideal for those with chronic pain conditions like arthritis or migraines.